99
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Fluocinolone Acetonide Intravitreal Implants in Vogt-Koyanagi-Harada Disease

, MD, , BA & , MD, MS
Pages 431-433 | Received 20 May 2009, Accepted 17 Aug 2009, Published online: 09 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Luz Elena Concha-Del Rio, Pilar Uribe-Reina & Alejandra De-La-Torre. (2021) Allergy against Steroids in Ocular Inflammation. Ocular Immunology and Inflammation 29:7-8, pages 1633-1638.
Read now
Clovis Arcoverde Freitas-Neto, Armin Maghsoudlou, Swetha Dhanireddy, Abhishek Payal, Sutasinee Boonsopon, Malinga D. Ratwatte & C. Stephen Foster. (2015) Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants. Ocular Immunology and Inflammation 23:6, pages 425-429.
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opinion on Pharmacotherapy 15:15, pages 2141-2154.
Read now
Sonia Attia, Sana Khochtali, Rim Kahloun, Sonia Zaouali & Moncef Khairallah. (2012) Vogt–Koyanagi–Harada disease. Expert Review of Ophthalmology 7:6, pages 565-585.
Read now
Sana S Siddique, Rajiv Shah, Ana M Suelves & Charles Stephen Foster. (2011) Road to remission: a comprehensive review of therapy in uveitis. Expert Opinion on Investigational Drugs 20:11, pages 1497-1515.
Read now
Jane S Myung, Grant D Aaker & Szilárd Kiss. (2010) Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant. Clinical Ophthalmology 4, pages 1423-1426.
Read now

Articles from other publishers (17)

TarekR Elhamaky. (2022) Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis. Indian Journal of Ophthalmology 70:7, pages 2465.
Crossref
Jong G. Park, Natalia F. Callaway, Cassie A. Ludwig & Vinit B. Mahajan. (2020) Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis. American Journal of Ophthalmology Case Reports 19, pages 100859.
Crossref
Akshay S. Thomas. 2020. Uveitis. Uveitis 43 99 .
Emily Su, Vikash S. Oza & Paul Latkany. (2019) A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab. Journal of the Formosan Medical Association 118:5, pages 945-950.
Crossref
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref
Ghazala A. Datoo O'Keefe & Narsing A. Rao. (2017) Vogt-Koyanagi-Harada disease. Survey of Ophthalmology 62:1, pages 1-25.
Crossref
Cynthia X. Qian & Dean Eliott. 2017. Uveitis. Uveitis 317 327 .
Marcelo Mendes Lavezzo, Viviane Mayumi Sakata, Celso Morita, Ever Ernesto Caso Rodriguez, Smairah Frutuoso Abdallah, Felipe T. G. da Silva, Carlos Eduardo Hirata & Joyce Hisae Yamamoto. (2016) Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet Journal of Rare Diseases 11:1.
Crossref
JANG WON Heo, Bum-Joo Cho, Debra A. Goldstein, Yasir J. Sepah, Diana V. Do & QUAN DONG Nguyen. (2016) FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT–KOYANAGI–HARADA DISEASE. Retina 36:11, pages 2124-2131.
Crossref
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble & C. Stephen Foster. (2016) Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity Reviews 15:8, pages 809-819.
Crossref
Sarah A. Logan, Christina Y. Weng & Petros E. Carvounis. (2016) Intravitreal Steroid Implants in the Management of Retinal Disease and Uveitis. International Ophthalmology Clinics 56:4, pages 127-149.
Crossref
Eun Kyu Oh, Eun Kyoung Lee & Hyeong Gon Yu. (2014) Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis. Canadian Journal of Ophthalmology 49:3, pages 273-278.
Crossref
Viviane Mayumi Sakata, Felipe Theodoro da Silva, Carlos Eduardo Hirata, Jozélio Freire de Carvalho & Joyce Hisae Yamamoto. (2014) Diagnosis and classification of Vogt–Koyanagi–Harada disease. Autoimmunity Reviews 13:4-5, pages 550-555.
Crossref
Miguel Cordero. 2012. Tratamiento de la uveítis con fármacos anti-TNF-alfa. Tratamiento de la uveítis con fármacos anti-TNF-alfa 55 59 .
Rosa Dolz-Marco, Roberto Gallego-Pinazo & Manuel Díaz-Llopis. (2011) Rituximab in refractory Vogt–Koyanagi–Harada disease. Journal of Ophthalmic Inflammation and Infection 1:4, pages 177-180.
Crossref
Ahmed Sallam, Simon R.J. Taylor & Sue Lightman. (2011) Review and update of intraocular therapy in noninfectious uveitis. Current Opinion in Ophthalmology 22:6, pages 517-522.
Crossref
Marc D. de Smet, Simon R.J. Taylor, Bahram Bodaghi, Elisabetta Miserocchi, Philip I. Murray, Uwe Pleyer, Manfred Zierhut, Talin Barisani-Asenbauer, Phuc LeHoang & Sue Lightman. (2011) Understanding uveitis: The impact of research on visual outcomes. Progress in Retinal and Eye Research 30:6, pages 452-470.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.